These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31466938)
1. Expression patterns of aquaporin 1 in vascular tumours. Narváez-Moreno B; Sendín-Martín M; Jiménez-Thomas G; Sánchez-Silva R; Suárez-Luna N; Echevarría M; Bernabeu-Wittel J Eur J Dermatol; 2019 Aug; 29(4):366-370. PubMed ID: 31466938 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Lincoln DT; Singal PK; Al-Banaw A Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592 [TBL] [Abstract][Full Text] [Related]
3. The genetics of vascular tumours: an update. Torrence D; Antonescu CR Histopathology; 2022 Jan; 80(1):19-32. PubMed ID: 34958509 [TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Dictor M; Rambech E; Way D; Witte M; Bendsöe N Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485 [TBL] [Abstract][Full Text] [Related]
5. What is new in endothelial neoplasia? Papke DJ; Hornick JL Virchows Arch; 2020 Jan; 476(1):17-28. PubMed ID: 31463731 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. Requena L; Sangueza OP J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Kahn HJ; Bailey D; Marks A Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy. Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372 [TBL] [Abstract][Full Text] [Related]
9. Tumor-Associated Protein Profiles in Kaposi Sarcoma and Mimicking Vascular Tumors, and Their Pathological Implications. Lee KB; Lee KS; Lee HS Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252633 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors. Kang GH; Kwon GY; Kim CW J Korean Med Sci; 1998 Feb; 13(1):54-9. PubMed ID: 9539320 [TBL] [Abstract][Full Text] [Related]
12. Angiogenic growth factor expression in benign and malignant vascular tumours. Young RJ; Fernando M; Hughes D; Brown NJ; Woll PJ Exp Mol Pathol; 2014 Aug; 97(1):148-53. PubMed ID: 24984271 [TBL] [Abstract][Full Text] [Related]
13. Canine vascular neoplasia--a population-based clinicopathologic study of 439 tumours and tumour-like lesions in 420 dogs. Gamlem H; Nordstoga K; Arnesen K APMIS Suppl; 2008; (125):41-54. PubMed ID: 19385280 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic implication of Kaposi's sarcoma-associated herpesvirus with special reference to the distinction between spindle cell hemangioendothelioma and Kaposi's sarcoma. Hisaoka M; Hashimoto H; Iwamasa T Arch Pathol Lab Med; 1998 Jan; 122(1):72-6. PubMed ID: 9448021 [TBL] [Abstract][Full Text] [Related]
15. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma. Dictor M; Fernö M; Baldetorp B Anal Quant Cytol Histol; 1991 Jun; 13(3):201-8. PubMed ID: 1910421 [TBL] [Abstract][Full Text] [Related]
17. Imaging of vascular tumors with an emphasis on ISSVA classification. Nozaki T; Matsusako M; Mimura H; Osuga K; Matsui M; Eto H; Ohtake N; Manabe A; Kusakawa I; Tsutsumi Y; Nosaka S; Kamo M; Saida Y Jpn J Radiol; 2013 Dec; 31(12):775-85. PubMed ID: 24135879 [TBL] [Abstract][Full Text] [Related]
18. WT1 expression in angiogenic tumours of the skin. Timár J; Mészáros L; Orosz Z; Albini A; Rásó E Histopathology; 2005 Jul; 47(1):67-73. PubMed ID: 15982325 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. Requena L; Sangueza OP J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670 [TBL] [Abstract][Full Text] [Related]
20. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF; Tognazzi K; Dvorak HF; Harrist TJ Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]